Form 4 for MED MEDIFAST INC
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0001628280-24-005405 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-16 | 2024-02-14 | MED | Maloney James P. | CFO | A - Grant | $0.00 | +2,328 | 12.1K | +24% | $0 | |
| 2024-02-16 | 2024-02-14 | MED | Maloney James P. | CFO | F - Tax | $52.68 | -648 | 11.4K | -5% | -$34.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | A | A | 2,328 | $0.00 | 12,080 | D | — | — | (F1) 1,164 Performance Stock Units were granted on March 17, 2021, and vested on December 31, 2023 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 14, 2024 and the shares were released on February 14, 2024. |
| 2 | Common | Common Stock | 2024-02-14 | F | D | 648 | $52.68 | 11,432 | D | — | — |